[ACRS] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
10-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 23.39%
YoY- 39.24%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 2,398 2,528 1,453 1,777 1,407 5,041 1,118 13.54%
PBT -16,941 -28,160 -18,789 -28,754 -15,328 -37,565 -30,229 -9.19%
Tax 200 -1,758 -1,318 16,439 -318 0 0 -
NP -16,941 -26,402 -17,471 -28,754 -15,586 -37,565 -30,229 -9.19%
Tax Rate - - - - - - - -
Total Cost 19,339 28,930 18,924 30,531 16,993 42,606 31,347 -7.72%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -706.46 -1,044.38 -1,202.41 -1,618.12 -1,107.75 -745.19 -2,703.85 -20.02%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.24 -0.39 -0.28 -0.57 -0.37 -0.91 -0.98 -20.88%
EPS Diluted -0.24 -0.39 -0.28 -0.57 -0.37 -0.91 -0.98 -20.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.